Leonteq Securities’s Teva Pharmaceutical Industries TEVA Stock Holding History
Bought
Maintained
Sold
Other funds holding TEVA
Leonteq Securities's TEVA Position: Q3 2026 in Review
Leonteq Securities sold out of Teva Pharmaceutical Industries (TEVA) in Q3 2026, closing a stake of 1,063 shares — an estimated $36K sold.
Leonteq Securities first reported a position in TEVA in Q4 2020 and held it in 22 quarters. The position peaked at $3.34M in Q3 2023. 595 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.
- Leonteq Securities reported no remaining Teva Pharmaceutical Industries position as of Q3 2026 after selling out during the quarter.
- Leonteq Securities sold 1,063 Teva Pharmaceutical Industries shares in Q3 2026, an estimated $36K.
- Leonteq Securities first reported a position in Teva Pharmaceutical Industries in Q4 2020 and held it in 22 quarters.
- Leonteq Securities's Teva Pharmaceutical Industries position peaked at $3.34M in Q3 2023.
- 595 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.